CSF3 and Alzheimer disease: Other clinical trials assessing the safety and efficacy of G-CSF in Alzheimer’s disease (ClinicalTrials.gov NCT01617577), ALS (ClinicalTrials.gov NCT01825551), brain injury and other neurodegenerative diseases (ClinicalTrials.gov NCT02236065) are being conducted.